Levels of phosphorylated JNK, p38, and ERK 1/2 MAPKs are increased in the postmortem brains of AD patients and inhibit their phosphorylation supply the methods to the treatment of AD [55,56]. This evidence concerns the gene MAPK8 and Alzheimer disease.